Johnson & Johnson’s Arrowhead Research ARWR Stock Holding History

Johnson & Johnson’s Portfolio ARWR Stock Details ARWR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-247,598	Closed	-$8.54M	–	18
2025 Q3	$8.54M	Hold	247,598	–	–	1.69%	10
2025 Q2	$3.98M	Hold	247,598	–	–	1.19%	10
2025 Q1	$3.15M	Hold	247,598	–	–	0.92%	10
2024 Q4	$4.65M	Hold	247,598	–	–	1.21%	12
2024 Q3	$4.8M	Hold	247,598	–	–	1.12%	12
2024 Q2	$6.44M	Hold	247,598	–	–	1.61%	12
2024 Q1	$7.08M	Hold	247,598	–	–	0.16%	13
2023 Q4	$7.58M	Hold	247,598	–	–	0.17%	13
2023 Q3	$6.65M	Hold	247,598	–	–	2.45%	12
2023 Q2	$8.83M	Hold	247,598	–	–	2.74%	10
2023 Q1	$6.29M	Hold	247,598	–	–	2.05%	11
2022 Q4	$10M	Hold	247,598	–	–	2.92%	10
2022 Q3	$8.18M	Sell	247,598 -1,013,271	-80%	-$40.9M	2.41%	11
2022 Q2	$44.4M	Hold	1,260,869	–	–	11.34%	3
2022 Q1	$58M	Sell	1,260,869 -2,000,000	-61%	-$99M	10.96%	4
2021 Q4	$216M	Hold	3,260,869	–	–	24.61%	1
2021 Q3	$204M	Buy	+3,260,869	New	+$211M	17.86%	2

Other funds holding ARWR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Johnson & Johnson's ARWR Position: Q4 2025 in Review

Johnson & Johnson sold out of Arrowhead Research (ARWR) in Q4 2025, closing a stake of 247,598 shares — an estimated $8.54M sold.

Johnson & Johnson first reported a position in ARWR in Q3 2021 and held it in 17 quarters. The position peaked at $216M in Q4 2021. 401 funds tracked by Wall St. Rank hold ARWR as of Q4 2025.

Johnson & Johnson reported no remaining Arrowhead Research position as of Q4 2025 after selling out during the quarter.
Johnson & Johnson sold 247,598 Arrowhead Research shares in Q4 2025, an estimated $8.54M.
Johnson & Johnson first reported a position in Arrowhead Research in Q3 2021 and held it in 17 quarters.
Johnson & Johnson's Arrowhead Research position peaked at $216M in Q4 2021.
401 funds tracked by Wall St. Rank held Arrowhead Research as of Q4 2025.

Based on Johnson & Johnson's 13F filing for Q4 2025, filed 13 Feb 2026.